Reviewing Flamel Technologies

Reviewing Flamel Technologies


Flamel Technologies and Acura Pharmaceuticals are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitabiliy, analyst recommendations, earnings, institutional ownership, dividends, valuation and risk. Flamel Technologies has a beta of 1.41, indicating that its stock price is 41% more volatile than the S&P 500.



from Biotech News